Rekord LOINC: 76544-6
Tylko wersja angielska ACTIVE
Szczegóły rekordu LOINC
Informacje podstawowe
| Kod LOINC: |
76544-6
FHIR
|
| Long Common Name: | Breast cancer 10-year risk of distant recurrence score Calculated by Prosigna |
| Short Name: | Brst ca 10Y dist recur score Prosigna |
| Status: | ACTIVE |
| Class Type: | 1 |
Fully Specified Name (FSN)
EN
Oryginalna wersja angielska
Breast cancer 10Y risk of distant recurrence score
:
Score
:
Pt
:
^Patient
:
Qn
:
Calculated.Prosigna
Klasyfikacja
| Class: |
ENMOLPATH
|
| Consumer Name: | - |
| Order/Observation: | Both |
| Panel Type: | - |
Informacje dodatkowe
| Units Required: | - |
| Example Units: | score |
| UCUM Units: | {score} |
| Version Last Changed: | 2.73 |
Definicja i opis
EN
The 10-year breast cancer distant recurrence risk score (also referred to as ROR Score or Risk of Recurrence Score) is a numerical score on a scale of 0 -100 that is calculated using a statistical model that includes: 1) the results from a 50-gene expression assay performed on formalin fixed paraffin embedded breast tumor tissue previously diagnosed as invasive carcinoma; 2) proliferation score; and 3) gross tumor size. The calculated score and information about lymph node status are used together to classify the patient into a risk category for distant breast cancer recurrence at 10 years. This term was created for the Prosigna™ Breast Cancer Prognostic Gene Signature assay, which is intended for use in postmenopausal women with node-negative (Stage I or II) or node-positive (Stage II), hormone receptor-positive (HR+) breast cancer who have undergone surgery and are to be treated with adjuvant endocrine therapy alone.
Powiązane nazwy
breast cancer; Brst ca 10Y risk dist recur score; Calc; Calc.Prosigna; Calculation; Molecular pathology; MOLPATH; PAM50; Point in time; Prosigna; Psoriasis Care Satisfaction questionnaire; QNT; Quan; Quant; Quantitative; Random; Risk of recurrence score; ROR; Scale